Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Centessa Pharmaceuticals (CNTA) Revenue (2025)

Centessa Pharmaceuticals has reported Revenue over the past 1 years, most recently at $15.0 million for Q1 2025.

  • Quarterly Revenue changed N/A to $15.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $15.0 million for FY2025, N/A changed from the prior year.
  • Revenue was $15.0 million for Q1 2025 at Centessa Pharmaceuticals.
  • Over five years, Revenue peaked at $15.0 million in Q1 2025 and troughed at $15.0 million in Q1 2025.